Indocyanine Green for Penile Cancer: Efficacy and Safety

What is it about?

The study investigated the safety and efficacy of indocyanine green (ICG) fluorescence-guided inguinal lymph node dissection (ILND) in patients with penile cancer. A prospective, single-blind, randomised controlled clinical trial was conducted among 45 patients in China. The results showed that ICG fluorescence-guided ILND was safe and improved the number of ILNs retrieved and reduced the LN non-compliance rate without increased complications. The total number of ILNs retrieved was higher on the ICG side than on the non-ICG side, and the LN non-compliance rate was lower on the ICG side than on the non-ICG side. The study concludes that ICG fluorescence-guided ILND is beneficial and recommended for selected patients with penile cancer.

Featured Image

Why is it important?

The study investigates the safety and efficacy of indocyanine green (ICG) fluorescence-guided inguinal lymph node dissection (ILND) in patients with penile cancer. It is important because improving surgical staging in the management of penile cancer can lead to better treatment decisions and outcomes. The study's findings suggest that ICG fluorescence-guided ILND is a safe and beneficial procedure for patients with penile cancer, as it can efficiently retrieve more ILNs and reduce the non-compliance rate without increasing the risk of surgical complications. Key Takeaways: 1. ICG fluorescence-guided ILND is safe and beneficial for patients with penile cancer. 2. The procedure can improve the number of ILNs retrieved and reduce the LN non-compliance rate without increased complications. 3. The study demonstrates that ICG fluorescence-guided ILND can effectively enhance the efficacy of ILND in patients with penile cancer.